Deva Holding AS | DEVA - Gross Profit On Sales


Deva Holding AS reported TRY1.32B in Gross Profit on Sales for its fiscal quarter ending in September of 2023.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 17.77M 3.46M Jun/2026
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 761K 298K Jun/2026
Ionis Pharmaceuticals USD 240M 25M Sep/2026
IQVIA Holdings USD 1.18B 258M Sep/2026
Moderna USD 995M 945M Sep/2026
Organon & Co USD 869M 22M Sep/2026
Revvity USD 418.58M 1.71M Sep/2026
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.44B 133.7M Sep/2026
Xeris Pharmaceuticals USD 79.59M 7.03M Jun/2026